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1. Introduction 
During recent years desmosomal research has developed into a biomedical field focused on 
the role of desmosomal components in tissue development and homeostasis. Investigators’ 
area of interest involves the influence of cell adhesion defects and abnormal cell signaling on 
cancer invasion and metastasis. Some data indicated that there is greater cell proliferation 
activity in basal cell carcinoma (BCC) than suggested by the clinically apparent slow growth 
of the tumor. Indeed, it may suggest that individual desmosomal cadherins play different 
roles in proliferation and differentiation in BCC. Thus, the functional importance of 
desmosomal cadherins in the adhesion of carcinoma cells and during destructive/invasive 
growth makes them a useful tool for the evaluation of the biological behaviour of BCC. 
2. Basal cell carcinoma: Clinical and histological subtypes 
BCC is the most common type of skin cancer with rising incidence trends. It originates from 
basal cell layers of epidermis and/or the pilosebaceous adnexa (Yu et al., 2008). It is usually 
slow growing and rarely metastasizes; however, it can cause clinically significant local 
destruction and disfigurement when neglected or inadequately treated (Wong et al., 2003, 
Telfer et al., 2008). Prognosis is excellent with proper therapy. Growth of BCC is usually 
localized to the area of its origin (Bath-Hextall et al., 2004). BCCs typically occur in adults, 
but the tumors can develop even in children (Kossard et al., 2006; Hakverdi et al., 2011). 
Furthermore, males show higher incidence of BCC than females (Bath-Hextall et al., 2004). 
The etiology of BCC is still unclear but appears to be of multifactorial origin, resulting from 
a complex interaction of both environmental and genetic factors (Hakverdi et al., 2011). 
Still, little is known about the genetic mechanisms underlying BCC (Teh et al., 2005). The 
genetic predisposition can be associated with, for example, genomewide allelic changes such 
as losses of chromosomal fragments leading to losses of heterozygosity (LOH) from a single 
DNA sample (Greinert, 2009), which are the most frequent genetic alternation in BCC (Gailani 
et al., 1996). In BCCs LOH is usually restricted to chromosome arm 9q (Greinert, 2009) and de 
novo mutations in the Patched 1 (PTCH) were found in 69% BCCs with 9q LOH (Teh et al., 
2005). It was suggested that mutations in gene on chromosome 9q22 may be a necessary event 
for basal cell carcinogenesis (Gailani et al., 1996). Genes of importance to BCC development 
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include PTCH1, P53 and MC1R, and many other recently discovered genes, which probably 
also play a role in BCC pathogenesis (de Zwaan & Haass, 2010). Moreover, twin studies and 
other studies of familial aggregation suggest a genetic predisposition to this cancer (de Zwaan 
& Haass, 2010). BCC may be divided into various clinical and histological subtypes. Using 
cDNA microarrays it is suggested that phenotypic diversity of BCCs might be accompanied by 
a corresponding diversity in gene expression patterns (Yu et al., 2008). 
Various types of cutaneous lesions may be a clinical manifestation of BCC. There have been 
also many histological subtypes of BCC described by various authors. The highest number, 26 
subtypes was described by Wade et al. (Wade & Ackerman, 1978). Thus, the nosology system 
of BCC requires simplification and clustering which may lead to a more practical classification 
(Mosterd et al., 2009). Clinical and histological subtypes of BCC may exhibit different patterns 
of behaviour and may even have a different etiology (Yu et al., 2008). The distinction between 
different BCC variants is important for prognosis and treatment (Yu et al., 2008). 
There are two basic criteria in histological classifications of BCC: the histological growth 
pattern and histological differentiation. The growth pattern of BCC is probably associated 
with its risk for recurrence (Vantuchová & Čuřík, 2006).  
According to WHO classification 2006 (Kossard et al., 2006) BCC may be divided into eight 
subtypes (Table 1): 
 
 Clinical subtypes Histological subtypes 
Superficial 
Characterized by a flat, red, well-circumscribed 
plaque with slow centrifugal spread. It may 
present as multiple lesions. Different sizes: from a 
few millimeters to over 10 cm in diameter. A fine 
pearly border or central superficial erosions with a 
history of contact bleeding may be present. It 
develops most frequently in areas where skin is 
covered (especially on the trunk). 10-30% of BCC 
Presence of superficial lobules of basaloid 
cells which project from the epidermis or 
from the sides of follicles or eccrine ducts 
into the dermis and are surrounded by 
loose myxoid stroma. Usually there 
appear to be multiple tumor foci, 
separated by areas of normal skin. 
Nodular 
Elevated pearly nodules associated with 
teleangiectasia. It may become ulcerated or cystic. 
It develops most frequently on the head. 60-80% of 
BCC. 
Presence of large lobules of basaloid cells 
(“germinative cells”) with peripheral 
palisading of the nuclei. The lobules may 
have associated mucinous degeneration 
with cysts or have an adenoid pattern. 
Micronodular 
Elevated or flat infiltrative tumor. It develops most 
frequently on the back. 
Presence of small nodules that permeate 
the dermis. In contrast to nodular BCC the 
surgical margins of micronodular BCC 
may be underestimated. 
Infiltrating 
Pale, indurated, poorly-defined plaque. It is most 
often found on the upper trunk or face. 
Presence of strands, cords and columns of 
basaloid cells with scant cytoplasm. 
Fibroepithelial 
Elevated flesh coloured or erythematous nodule 
that may resemble a seborrhoic keratosis or 
acrochordon. It develops most frequently on the 
back. 
Presence of an arborising network of 
cords of basaloid cells that extend 
downwards from the epidermis and 
create a fenestrating pattern. 
With adnexal 
differentiation 
No distinguishing clinical features. 
Presence of adnexal differentiation 
including basaloid buds, ductal, 
sebaceous, and trichilemmal elements. 
Basosquamous No distinguishing clinical features. 
Presence of abundant cytoplasm with 
more marked keratinization than typical 
BCC. The nuclei have vesicular chromatin 
with pleomorphism. 
Keratotic 
It appears pearly and may be studded with small 
keratin cyst (milia). 
It shares the overall features of a nodular 
BCC. Keratinization may be laminated. 
Table 1. Subtypes of BCC 
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Still, it should be emphasized that individual BCCs, when their total mass is examined, may 
exhibit combined features of various histological subtypes. 
3. Desmosomal cadherins: Molecular biology and distribution in 
physiological and pathological conditions  
Desmosomal cadherins (DCs) are transmembrane glycoproteins, which belong to the 
group of calcium-dependent intercellular adhesion molecules. They may initiate and 
maintain cell-cell adhesion in the absence of any contribution from classical cadherins 
(Garrod et al., 2002). DCs involve two subfamilies: i) the desmogleins (DSGs), ii) the 
desmocollins (DSCs) (Bazzi et al., 2006; Ishii, 2007; Brennan et al., 2004, Koch et al., 1992). 
So far three isoforms, each in two splicing variants, of desmocollin (DSC1-3) and four 
isoforms of desmoglein (DSG1-4) are known in humans (Ishii, 2007; Brennan et al., 2004).  
An additional two DSGs, DSG5 and DSG6, are present in mice (Whittock, 2003). 
Alternative splicing of the cytoplasmic domain gives rise to a longer “a” and a shorter “b” 
form of each DSC isoforms (Garrod et al., 2002). It is known that DSG and DSC have 
approximately 30% amino acid identity with each other and with the classical cadherins. 
They all have homologic basic structure in their extracellular domains and possess in the 
amino-terminal EC1 ectodomain cell adhesion recognition (CAR) sites with a central 
alanine residue. In light of above, researchers, using transfected fibroblasts, shown that 
adhesion mediated by DSC2/DSG2 and DSC3/DSG3 could be specifically blocked by 
peptides (Garrod et al., 2002). 
In humans the genes encoding DCs are clustered on the q arm of chromosome 18 (Fig.1), so 
the possibility exists that DC gene expression is controlled through a common locus control 
element (Smith et al., 2004). Each DCs arise from a distinct gene and they are generally 
expressed in a differentiation-specific manner. This may suggest that in addition to their 
adhesive function, they may have a direct or indirect role in regulating differentiation 
(Garrod et al., 2002). Thus, the correlation between DCs and the stage of 
differentiation/proliferation allows creating the hypothesis that changes in gene function 
resulting from mutations would lead to alternation in differentiation/proliferation of hair 
follicle and epidermal cells (Cserhalmi-Friedman et al., 2001; Smith et al., 2004). This idea is 
supported by the results of transgenic mice experiment in which mis-expression or target 
ablation of DCs has resulted in altered patterns of epidermal differentiation. The DSGs 
genes are arranged in the following order: DSG1, DSG4, DSG3, DSG2 from centromeric to 
telomeric direction in the cadherin gene locus (Mahoney et al., 2006). Interestingly, this 
organization of genes correlates with DSGs expression in the epidermis (Mahoney et al., 
2006). Thus, DSG1 and DSG4 are expressed in the differentiated cells of epidermis while 
DSG3 and DSG2 are localized to the proliferative basal and suprabasal cells of epidermis 
(Mahoney et al., 2006).  
Various studies on adult human and bovine tissues have established that the DSGs and 
DSCs are both expressed in tissue-specific and differentiation-dependent patterns (King et 
al., 1993, 1997). This type of DCs expression implies that desmosomes within different 
tissues are biochemically, and presumably functionally, distinct (Delava et al., 2011). Delava 
et al. demonstrated that the precise role for the tissue-specific expression patterns of 
desmosomal cadherins is not fully understood, but manipulation of their expression 
suggests that this regulation is critical to tissue homeostasis (Delava et al., 2011). 
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Fig. 1. Molecular biology of human desmosomal cadherins: genes reside in a genomic 
cluster on the q arm of human chromosome 18 
3.1 Expression of desmosomal cadherins in normal tissue 
The DCs show complex patterns of expression, particularly in intermediate layers where 
the majority of isoforms are expressed. However, the molecular mechanisms regulating 
DCs expressions are not well studied, particularly at the transcriptional level (Bazzi et al., 
2006). Researchers, analyzing mRNA expression, suggested spatial patterns of DCs genes 
transcription and hierarchical expression of individual genes (King et al., 1997). However, 
most of the findings described the DC expression pattern at protein level. Nevertheless, 
Mahoney et al. (Mahoney et al., 2002) noticed that DSGs share high homology at both the 
gene and protein level and their expression is spatially and temporally regulated 
(existence of systems that provide both temporal and spatial control for transgene 
expression). This fact may potentially be contributing to significant role of DSGs in  
cell-cell adhesion during development (Mahoney et al., 2002).  All desmosomes possess at 
least one DSC and one DSG but it appears to be no barrier to the presence of more than 
one of each (Chidgey, 2002; North et al., 1996; King et al., 1997).  Data obtained with the 
use of mRNA and protein analyses shown that DCs are formed in the skin in relation to 
differentiation (Moll et al., 1997). 
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Expression pattern of DSGs in normal human epidermis was shown in Fig. 2. DSG1 and 
DSG3 are restricted to stratified epithelia (Brennan et al., 2010). DSG1 is more intensively 
expressed as the cells differentiate toward the stratum corneum, and very little detectable in 
the basal layer, whereas DSG3 is localized to the basal and immediate suprabasal layers (Wu 
et al., 2003). In normal human epidermis, DSG2 is expressed at low levels, and was reported 
to be restricted to the lowermost epidermis (Brennan et al., 2010). DSG2 expression fades 
with keratinocyte differentiation, whereas DSG3 expression decreases somewhat gradually 
from the basal into the spinous cell layers (Bowszyc-Dmochowska et al., 2010). DSG4 
expression is restricted to the highly differentiated upper cell layers (Ishii, 2007), what is 
confirmed at both the mRNA and protein level (Bazzi et al., 2006). Expression of DSG4 may 
first be detected in the lower granular layers, increases in intensity upward into the horny 
layers, and terminates as the cells die to form the protective barrier (Mahoney et al., 2006). 
There is a hypothesis that DSG4 may coincide with the downregulation of DSG1 (Mahoney 
et al., 2006). Interestingly, the genes for DSCs are also differentially expressed. DSC1 is 
confined to the suprabasal cell layers, whereas DSC2 and 3 are found in desmosomes 
throughout the interfollicular epidermis (Moll et al., 1997). 
Molecular cloning of DSGs and analysis of intron/exon organization of the DSG mice genes 
revealed significant conservation (Mahoney et al., 2002). Some studies indicated that 
expression of DSGs mRNA during mouse embryonic development and in various adult 
tissues are variable (Mahoney et al., 2002). This group of researchers shown that in adult 
mouse tissues, DSG2 is widely expressed while DSG1 and DSG3 expression is restricted to 
selected tissues (Mahoney et al., 2002). 
 
 
Fig. 2. Pattern of expression of desmogleins and desmocollins in normal human epidermis 
Hair follicles exhibit morphological and ontogenic continuity with the epidermis. The 
distribution of DSGs in hair follicles (Fig. 3) has been described in some studies.  Similar to 
epidermis, hair follicle is compartmentalized into a hierarchy of cells types based on the 
level of differentiation (Wu et al., 2003). DSG1 is expressed in the inner root sheath, and the 
innermost layers of the outer root sheath. There is a report that DSG2 is highly expressed by 
the least differentiated cells of the cutaneous epithelium, including the hair follicle bulge of 
fetus and adult, bulb matrix cells, and basal layer of the outer root sheath (Wu et al., 2003). 
Expression of DSG3 in hair follicle is correlated with different types of keratinization (all 
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layers of outer root sheath in areas of trichilemmal keratinization and mainly the basal layer 
in areas of epidermal-like keratinization) (Wu et al., 2003). DSG4 is expressed specifically in 
hair shaft cortex, lower hair cuticle, and upper inner root sheath cuticle (Bazzi et al., 2009), 
what corroborated with findings based on DSG4 mRNA obtained by Bazzi et al. (Bazzi et al., 
2006). Probably this molecule is a key mediator of keratinocyte cell adhesion in hair follicle, 
where it coordinates the transition from proliferation to differentiation (Brennan et al., 2010). 
Analysis of expression of DSCs, with the use of monoclonal antibodies, in anagen hair 
follicles indicated that DSC1 is selectively localized in the inner root sheath. DSC2 is present 
in the area of cell borders of the central layer of the outer root sheath, while DSC3 shows 
increasing intensity with progressive differentiation (Kurzen et al., 1998).  
 
 
Fig. 3. Pattern of expression of desmogleins in normal human hair follicle. Desmogleins are 
marked as follows: red – DSG1, green – DSG2, blue – DSG3, yellow-DSG4  
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Recent studies have suggested that bulge region might be the reservoir of stem cells of 
hair follicles (Ma et al., 2004; Ohyama, 2007). Hair follicle stem cells are multipotent and 
having a superior clonogenicity and proliferative capacity. They are capable of giving rise 
to all cell types of hair, epidermis and sebaceous gland (Ma et al., 2004; Ohyama, 2007, Wu 
et al., 2003). Bulge cells might be susceptible to genetic alternation and be a source of 
carcinogenic mutations (Ohyama, 2007). Some data has suggested that several skin 
tumors, including BCC, might be derived from hair follicle cells, particularly from bulge 
cells (Ohyama, 2007). Most current data indicated (Grachtchouk et al., 2011) that probably 
there is a link between subtypes of BCC and its cell of origin, and constitutive hedgehog 
signaling activity. 
3.2 Desmosomal cadherins and tumorigenesis 
It is known that modulation or loss of intracellular junctions known as desmosomes has 
been implicated in tumorigenesis and contributes to the invasive and metastatic behavior of 
cancer cells (Teh et al., 2011). Beaudry et al. noted that probably desmosome loss does not 
promote tumorigenesis via a general trans-differentiation mechanism, but rather via more 
specific manner related to changes caused by complete desmosome-deficiency (Beaudry et 
al., 2010).  However, studies about expression of desmosome components during human 
cancer progression have generated conflicting results (Beaudry et al., 2010). Thus, further 
genetic studies with animal models, such as knockout mice, to evaluate the functional 
consequence of desmosome alternation for tumorigenesis are necessary (Beaudry et al., 
2010). Teh et al. found that downregulation of desmosomal components, particularly the 
DCs, precedes malignancy and is associated with desmosomal dysfunction (Teh et al., 2011). 
Beaudry et al. studying Perp-lacking mice demonstrated that Perp-deficiency indeed leads 
to accelerated skin tumorigenesis and PERP protein may be important as a tumor 
suppressor in humans (Beaudry et al., 2010).    
Findings obtained by Teh et al. indicated that decreased assembly of desmosomes or down-
regulation of desmosomal proteins, including DCs, is associated with several epithelial 
cancers (Teh et al., 2011). Studies on the role of DCs in BCC are relatively scanty in relation 
to squamous cell carcinoma (SCC), while it seems that BCC is the most common type of skin 
cancer. Better understanding of molecular basis of BCC may also lead to improvement 
therapeutic approaches. However, to the best of our knowledge, there have been no 
definitive data about the expression of all of DCs in BCC. Still, several reports (Mahoney et 
al., 2010; Bazzi & Christiano, 2007) indicated that the expression of DCs in tumor cells may 
be associated with the invasive or metastatic ability of various skin carcinomas, including 
BCC (Gornowicz et al., 2009). Although the mechanism by which DCs affect the 
tumorigenesis has not be fully elucidated and require further investigation (Tada et al., 
2000). Consequently, the cell-cell adhesions of BCC represent an interesting field of 
examination (Moll et al., 1997). 
Elegant study showed that, in SCC, during desmosome assembly, DSG3 first forms simple 
clusters at the cell surface (Garrod et al., 2002). Then the incorporation of desmosomal 
cadherin into the desmosomes was isoform-dependent (Ishii et al., 2001). Probably DSG2 
and DSG3 were incorporated, but DSG1 and DSC1a were not. DSG1 normally expressed in 
the upper layers of epidermis, so the importance of a differentiation program for expression 
was stressed (Ishii et al., 2001). 
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Electron microscope studies of BCC revealed a significant reduction of desmosomes 
compared with normal basal cells and hair follicle keratinocytes (Krunic et al., 1997). 
Dysfunction or loss of desmosomal cadherins are also possible events in the BCC and these 
events may precede overt malignancy. 
3.2.1 Expression of desmosomal cadherins in BCC 
The desmosomal immunostainig (plakophilin 1) observed in BCC was very heterogeneous: 
in general, junctions in well-differentiated stratified tumor regions were more intensely 
stained than sections of poorly differentiated and invasively growing BCCs (Moll et al., 
1997) 
Tada et al. using immunofluorescence with monoclonal antibody revealed that expression of 
DSG1 in BCC was decreased or absent in tumor cells, whereas the expression of E-cadherin 
was strongly positive (Tada et al., 2000). Moreover, all of examined by Tada et al. (Tada et al. 
2000) BCC cases showed no metastasis, then it is suggested that E-cadherin but not DCs may 
prevent the detachment of tumor cells from tumor nests. Bazzi et al. (Bazzi & Christiano, 
2007) indicated that the links between classical cadherin (such as E-cadherin) 
downregulation and metastasis through epithelial–mesenchymal transition are well 
established. However, they noticed that still it remains to be determined whether a similar 
link between desmosomes and cancer exists and if so, which desmosomal components are 
involved (Bazzi & Christiano, 2007). 
 
 
Fig. 4. Expression of DSG2 in BCC nests in patient with BCC. DSG2 expression in 
immunohistochemistry (top left) (immunoperoxidase staining on frozen sections), DSG2 
expression processed with digital microscopic image analysis superimposed on DSG2 
expression in immunohistochemistry (top right), intensity of DSG2 expression processed 
with digital microscopic image analysis (bottom) (original magnification x400). 
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It is suggested that only DSG2 may be found in tumors whereas the synthesis of other DSGs 
is much restricted. This hypothesis was corroborated by Schafer, who detected DSG2 in 
carcinoma cells with immunohistochemistry. Increased level of DSG2 in BCC was also 
observed in further investigation (Brennan & Mahoney 2009; Gornowicz et al., 2009). 
Brennan et al. identified DSG2 as a potential new marker for epithelial-derived malignancies 
and postulated that overexpression of DSG2 may deregulate multiple signaling pathways 
associated with increased growth rate, anchorage-independent cell survival, and the 
development of skin tumors (Brennan & Mahoney, 2009). In light of this, DSG2 
overexpression may activate signal transduction pathways such as PI3K/Akt, MAPK, 
STAT3 and NFkappaB, which are often involved in cell proliferation and survival (Brennan 
& Mahoney, 2009). This group of researchers also noticed that the current dogma in cancer 
biology is that cell adhesion is reduced during malignant transformation, in turn allowing 
malignant cells to migrate, invade and metastasize. These data are compatible with our 
results (Bowszyc-Dmochowska et al., 2010, 2011), which demonstrated, with quantitative 
digital morphometry, an increased expression of DSG2 in BCC nest compared to normal 
epidermis (Fig. 4, Fig. 5). Furthermore, we found a significant correlation (r=+0.6092) 
between intensities of DSG2 and DSG3 expression in normal epidermis, but no significant 
correlation between those markers in BCC. However, still the potential value of DSG2-
specific antibodies in tumor diagnosis as well as in studies of the mechanisms desmosomal 
cell coupling is discussed (Schäfer et al., 1996). 
 
 
Fig. 5. Expression of DSG2 in non-BCC-affected epidermis. DSG2 expression in 
immunohistochemistry (top left) (immunoperoxidase staining on frozen sections), DSG2 
expression processed with digital microscopic image analysis superimposed on DSG2 
expression in immunohistochemistry (top right), intensity of DSG2 expression processed 
with digital microscopic image analysis (bottom) (original magnification x400). 
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The studies on the expression of  DSG3 in human tumors are still scarce. Hence, the role and 
mechanism of DSG3 in cancer development remain to be elucidated. Study on expression of 
DSG3 in BCC (Gornowicz et al., 2009), using mathematical analysis of immunoperoxidase 
staining images, revealed that DSG3 expression is significantly decreased in BCC nest 
compared to both BCC-free epidermis in BCC patients (Fig. 6, Fig. 7) and patients with more 
benign tumors than BCC. Thus, these results seem to indicate that DSG3 might be involved 
in BCC pathogenesis as its decreased expression in BCC-affected epidermis might be 
responsible, in part, for locally invasive behavior of that tumor. The intriguing question 
arises what causes this decrease of expression of DSG3 in BCC, in other words whether it is 
a cause or result or somehow both of perturbed adhesion in BCC. It is noticed (Gornowicz et 
al., 2009) that the cooperation of p53/Perp (Kanellou et al., 2009; Bektas & Rubenstein 2009) 
pathways with DSG3 in regulating/disturbing keratinocyte adhesion in BCC is a sheer 
speculation at present, but this should be experimentally verified, especially as a role for 
Perp in DSG3-linked pemphigus vulgaris has recently been postulated (Nguyen et al., 2009).  
Alternatively, an exciting possibility is, giving the fact that tightly packed cancer cells 
showing a palisade arrangement on the periphery of the tumor are characteristic for BCC 
(Lever & Schaumburg-Lever, 1990), that the diminution/lack of DSG3-mediated adhesion is 
not enough for BCC cells to separate fully. In some cases of cancer the inhibition of tumor 
growth and invasion following the knockdown of DSG3 mediated by RNA interference 
(RNAi) was observed (Teh et al., 2011). RNAi is a powerful tool to dampen the level of 
proteins that are mutated or frequently overexpressed in skin diseases (Simpson et al., 2010). 
In BCC, perhaps, the DSG3 may be the target protein for RNAi. 
There is no report on the involvement of DSG4 in BCC pathogenesis. Our own experiments 
using a commercially available anti-DSG4 antibody (unpublished data) with 
immunohistochemical staining, despite repetitive attempts under various conditions, gave 
no satisfying results. We found unequivocal DSG4 expression neither in BCC nests nor in 
normal epidermis, whereas DSG4 appeared to be expressed in sweat glands. It is known 
that BCC may show differentiation resembling the adnexal structures, such as hair follicles, 
sebaceous glands, or eccrine and apocrine sweat glands (Haushild et al., 2008). Interestingly, 
eccrine sweat glands are generally considered as a possible epidermal stem cell source 
(Biedermann et al., 2010). Birdermann described both in vitro and in vivo the capability of 
human eccrine sweat gland cells to form a stratified interfollicular epidermis. Little evidence 
for a sweat gland origin of the basal cell tumor has been presented by previous investigators 
(Zackheim, 1963). The origin of BCC from sweat gland ducts has been recorded, but 
probably its origin from sweat gland acini is extremely rare, if not actually unknown 
(Arnold, 1948). Still, a plausible link between DSG4 expression in sweat glands and BCC 
showing sweat gland-like structures should be explored. 
Desmosomal and hemidesmosomal adhesion systems are downregulated in the hair  
matrix region of hair follicle and in BCC resulting from abnormal growth of developing  
hair follicles (Nanba et al., 2000). Some observation shown that the desmosomal adhesion 
system, in which the DCs of DSCs and DSGs function, is downregulated in hair placodes 
(Nanba et al., 2000). Furthermore, hair follicles, which physiologically express DSGs, 
apparently are involved in BCC pathogenesis (Gornowicz et al., 2009). Particularly, bulge 
cells are in the area of research interest, because of their possible role in tumorigenesis 
(Ohyama, 2007), including that of BCC. Several research groups have noted that some  
BCCs express K-15 that is usually expressed in human follicle bulge cells (Ohyama, 2007).   
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Fig. 6. Expression of DSG3 in BCC nests in patient with BCC. DSG3 expression in 
immunohistochemistry (top left) (immunoperoxidase staining on frozen sections),  
DSG3 expression processed with digital microscopic image analysis superimposed on  
DSG3 expression in immunohistochemistry (top right), intensity of DSG3 expression 
processed with digital microscopic image analysis (bottom)  
(original magnification x400). 
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Fig. 7. Expression of DSG3 in non-BCC-affected epidermis. DSG3 expression in 
immunohistochemistry (top left) (immunoperoxidase staining on frozen sections),  
DSG3 expression processed with digital microscopic image analysis superimposed on  
DSG3 expression in immunohistochemistry (top right), intensity of DSG3 expression 
processed with digital microscopic image analysis (bottom)  
(original magnification x400). 
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Interestingly, it has been found that overexpression of Shh gene (sonic hedgehog), a gene 
essential for hair follicle morphogenesis, resulted in the formation of BCC like tumors 
(Ohyama, 2007). However, Youssef et al. using murine model (Youssef et al., 2010) have 
very recently revealed that BCC does not originate from bulge stem cells, as previously 
thought. With the use of clonal analysis they have found using mouse model of the disease 
that BCC arises from long-term resident progenitor cells of the interfollicular epidermis and 
the upper infundibulum (Youssef et al., 2010). Still, DSGs can be important in BCC 
pathogenesis regardless of the issue of BCC cellular origins as they are expressed in both 
bulge region and the upper infundibulum of hair follicle and interfollicular epidermis 
(Gornowicz et al., 2009).  
Overall, what noticed Chidgey (Chidgey & Dawson, 2007), findings obtained by different 
authors demonstrate that alterations in DCs expression patterns, perhaps through modified 
intracellular signalling and/or changes in adhesive strength, have fundamental effects on 
cell behaviour, and can in some situations drive proliferation (Chidgey & Dawson, 2007). 
Thus, alterations in the expression of DCs in cancer could result in the release of plakoglobin 
from desmosomes, subsequent displacement of β-catenin from adherens junctions and 
increased Wnt/β-catenin signaling (Chidgey  & Dawson, 2007). 
3.3 Alternative splicing of DCs and tumorigenesis in BCC 
Alternative splicing (AS) generates mRNA that encodes different polypeptides from a single 
gene. Different protein isoforms of a single gene may have distinct or even antagonistic 
functions, due to the insertion or deletion of key functional regions (Xing, 2007). AS is a 
common phenomenon and more than 90% human genes are alternatively spliced (Pan et al., 
2008; Wang et al., 2008). It is known that AS is involved in numerous human diseases (Kim 
et al., 2007), thus accumulating evidence revealed that aberrant splicing contributes to 
human neoplasms (Miura et al, 2011; Xing, 2007; Kim et al., 2007; Venables, 2006; He et al., 
2007; Srebrow & Kornblihtt, 2006). However, in only few cases it has been proved,  
e.g. breast and ovarian cancer, prostate cancer (Lixia et al., 2007; Rohlfs et al., 2000; Thorsen 
et al., 2008; Rajan et al., 2009). Kim et al. shown that cancerous tissues exhibit lower levels of 
AS than do normal tissues, what might be a result of disruption of splicing regulatory 
proteins (Kim et al., 2007). 
AS is a fundamental molecular process which generates proteome functional diversity and 
may play a significant role in cell differentiation and proliferation, probably through the 
production of alternative transcripts of DCs. Srebrow et al. (Srebrow & Kornblihtt, 2006) 
indicated that the connection between the signaling pathways and splicing regulation can 
lead to the deregulation of proliferation and differentiation, which may contribute to cancer. 
The discovery of the events of AS in the DCs transciptome of BCC cells and understanding 
how AS contributes to tumorigenesis (Xing, 2007) may produce new medical implications, 
e.g. drug targets. However, the knowledge about AS in BCC is still limited. Some reports 
indicate that alternative splicing pattern of Mcl-1 (myeloid cell leukemia 1) may induce 
apoptosis in BCC (Shieh et al., 2009). 
Both DSGs and DSCs exist in multiple isoforms (Hardman 2004). It is known that DSCs 
occur as “a” and “b” splice variants (Hardman et al., 2004; Cheng et al., 2003) and these 
alternative transcripts have different function. The “a” variant having slightly longer 
cytoplasmic domain can support desmosomal assembly (Hardman et al., 2004; Cheng et al., 
2003). Some hypothesis indicate that “b” form mediates or regulates DSC signaling activity 
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through its distinct cytoplasmic domain; however, Hardman et al. observed that DSC3b 
may be involved in epidermal differentiation regulation (Hardman et al., 2004). 
Recent work revealed that the expression of DCs might be altered in cancers originating 
from keratinocytes (Lee et al., 2009). Lee et al. (Lee et al., 2009) examined expression of 
splicing variant of DSG3 in epidermal cancers, such as SCC and BCC. Their expression was 
highly increased in SCC, but not in BCC. These results suggest that splicing variant of DSG3 
may disturb desmosome assembly components and weaken the cell-cel interaction (Lee et 
al., 2009). Thus, AS of DCs may affect signaling in the cell and regulate process of epidermal 
differentiation and proliferation. 
Searching NCBI Gene Database by DSGs names revealed interesting issues. In humans, only 
DSG4 gene is described as having alternative splicing form (DSG4 isoform 1 and DSG4 
isoform 2). Interestingly, there is no NCBI data about AS in DSG1, DSG2 and DSG3 genes. 
However, some researchers (Lee et al., 2009) suggested that AS may generate a splicing 
variant of DSG3 (ΔNDg3). Thus, these results shown that molecular analyses of DCs should 
still be considered an important research area. It should be remembered that correct 
interpretation of genetic alternation and the investigation of aberrant transcripts is crucial 
for genetic diagnosis and molecular characteristics of neoplasms (Miura et al., 2011), 
including BCC. In light of this, oligonucleotide microarrays containing exon junction probes 
may be a powerful tool to investigate tissue-specific regulation of AS taking place in BCC 
(Nagao et al., 2005). Literature data may suggest that AS should be regarded as a potential 
source for new clinical diagnostic, prognostic and therapeutic strategies in cancer (He et al., 
2007). 
4. Conclusions 
Thus, it seems that DCs might be involved in BCC pathogenesis. Seemingly, the expressions 
of DSG2 and DSG3, adhesion molecules that plausibly play different roles in proliferation 
and differentiation of epidermis, are coordinated in normal epidermis, but this apparent 
coordination is lost in BCC. That loss of coordination of DSG2 and DSG3 expressions, 
revealed with quantitative digital morphometry, in BCC might be a partial explanation of 
BCC behaviour as a locally invasive tumor. 
There is still a very interesting issue, what role desmosomal adhesion and desmosomal 
components (particularly DSGs) play in carcinogenesis. The disturbance of desmosomal 
adhesion can result in tissue integrity damage and possibly induction of tumor cell 
migration and proliferation. Study on the role of DSG in BCC may suggest that in human 
skin DSG2-mediated adhesion appears to be more proliferation-associated, whereas DSG3-
mediated adhesion seemingly is more differentiation-associated. 
The impact of signaling pathway, involving DCs mediated adhesion, and cells of origin for 
BCC on different subtypes of BCC should be explained. Work with murine model, which 
was carried out by Grachtchouk et al. (Grachtchouk et al., 2011), shown that the level of 
expression of constitutive hedgehog pathway effector (GLI2*) is depended on histological 
BCC subtypes. Moreover, they indicated that phenotype of BCC may be determined by the 
cell of origin and tissue context. Thus, these connections may determine the different 
biological behavior of BCC. 
Progress in these areas will lead to a better understanding of the role of desmosomes in 
normal tissue homeostasis and malignancy (Chidgey & Dawson, 2007). 
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